OR52R1 Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This chemical could induce hypomethylation of the OR52R1 gene promoter, resulting in the attenuation of its transcriptional activity by altering the chromatin architecture. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
By inhibiting histone deacetylase, Trichostatin A may lead to the hyperacetylation of histones, which could repress the transcription initiation complex assembly at the OR52R1 locus. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat could lead to the hyperacetylation of histone proteins associated with the OR52R1 gene, causing a downregulation of its transcriptional output. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
The selective inhibition of Class I HDACs by MS-275 (Entinostat) might result in altered acetylation status of histones at the OR52R1 site, culminating in a diminished gene expression profile. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Methotrexate could lead to a depletion of nucleotide precursors, which may result in a reduced transcription rate of the OR52R1 gene due to a scarcity of essential transcription substrates. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
By inhibiting DNA methyltransferases, Decitabine could cause hypomethylation of the OR52R1 gene′s regulatory regions, potentially leading to decreased gene expression levels. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Disulfiram could indirectly lead to the repression of OR52R1 through the alteration of metal ion homeostasis, which may interfere with the binding of transcription factors to the OR52R1 promoter. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium Butyrate, through its HDAC inhibitory action, could induce histone hyperacetylation and subsequently repress the initiation of transcription at the OR52R1 gene locus. | ||||||
Temozolomide | 85622-93-1 | sc-203292 sc-203292A | 25 mg 100 mg | $89.00 $250.00 | 32 | |
Temozolomide could methylate the OR52R1 gene directly, potentially leading to transcriptional silencing or introduce mutations that could lead to the loss of functional OR52R1 transcript production. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Alpha-amanitin could inhibit the transcription of OR52R1 by binding to RNA polymerase II, leading to a halt in the elongation phase of mRNA synthesis for this gene. | ||||||